查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930169

全球生物偶聯市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測（2026-2034）

Bioconjugation Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 220 Pages | 商品交期: 請詢問到貨日

價格

生物偶聯市場成長因素

2025年全球生物偶聯市場規模達47.8億美元，從2026年的52.4億美元成長至2034年的113.9億美元，預測期內年複合成長率（CAGR）為10.20%。北美地區憑藉著強大的生物製藥研發活動和先進的生產能力，在2025年佔據生物偶聯市場51.82%的市場佔有率，成為該市場的主導地區。

生物偶聯是一種將兩種不同的分子（通常透過共價鍵）化學連接起來，形成功能性複合物的技術。這項技術廣泛應用於抗體藥物偶聯物（ADC）、診斷試劑、分子影像劑和標靶治療藥物的研發。對標靶治療日益成長的需求、研發投入的增加以及技術的不斷進步，加速生物偶聯技術在治療和診斷領域的應用。此外，生物製藥公司與合約研究、開發和生產機構（CRO/CDMO）之間合作的加強，也進一步推動了市場成長。

Thermo Fisher Scientific Inc.、Agilent Technologies Inc.、Lonza等領導企業憑藉其廣泛的服務、全球營運和強大的技術能力，引領市場。

市場動態

市場驅動因素

對抗體藥物偶聯物（ADC）的日益關注

對抗體藥物偶聯物（ADC）研發的日益關注是生物偶聯市場的主要驅動因素。抗體偶聯藥物（ADC）結合了單株抗體的特異性和細胞毒性藥物的效力，能夠以較低的全身毒性進行標靶癌症治療。位點特異性偶聯技術的進步提高了藥物的穩定性、療效和安全性，擴展了 ADC 的研發管線。

根據Hunan Huateng Pharmaceutical Co., Ltd.2025年 4月發布的資料，截至目前，全球共有 19 種 ADC 藥物已獲批上市。

市場限制因子

監理與安全挑戰

嚴格的法規要求和安全問題是限制市場成長的重要因素。新型生物偶聯藥物由於存在脫靶毒性和藥物過早釋放等風險，面臨複雜的監管路徑。這些因素可能會延長審批時間並增加研發成本，可能延緩商業化進程。

例如，2023年 7月，ADC Therapeutics SA 因安全性和有效性問題終止了 II 期 LOTIS-9 試驗。

市場機會

伴隨診斷及影像劑需求成長

生物偶聯透過將成像探針、放射性同位素和螢光染料連接到抗體或胜肽上，在精準診斷和分子成像中發揮關鍵作用。伴隨診斷和成像劑（尤其是在腫瘤學領域）的日益普及，為市場帶來了巨大的成長機會。

市場挑戰

高成本與技術複雜性

開發生物偶聯療法，特別是抗體藥物偶聯物（ADC），需要複雜的生產流程、先進的設施和廣泛的臨床試驗。根據美國國家生物技術資訊中心（NCBI）2023年 6月的一項研究，抗體偶聯藥物（ADC）療法的年費用在 10萬美元至 50萬美元之間，這限制了該療法的普及和廣泛應用。

生物偶聯市場趨勢

外包給 CRO 和 CDMO 的趨勢日益明顯

製藥和生物技術公司日益將偶聯和表徵活動外包給專業的CRO（合約研究組織）和 CDMO（合約開發和生產組織）。這一趨勢使公司能夠降低資本支出、獲得先進技術並加快開發進程。2024年 10月，龍沙公司擴大了與一家大型生物製藥公司在商業規模 ADC 生產方面的合作。

市場區隔分析

依產品/服務分類：

產品細分市場在2026年佔據主導地位，市場佔有率達75.83%，主要得益於藥物研發、診斷和研究領域對耗材的高需求。

依技術分類：

化學偶聯技術細分市場在2026年佔據最大市場佔有率，達47.68%，這主要歸功於其成本效益和廣泛的適用性。

依偶聯物類型劃分：

抗體藥物偶聯物（ADC）在強大的腫瘤產品線支持下，預計到2026年將佔據 56.91%的市場佔有率。

依應用領域劃分：

受標靶療法獲準數量不斷增加的推動，治療藥物領域佔據主導地位，到2025年達到 66.0%，預計到2026年將達到 66.74%。

依最終使用者劃分：

由於製藥和生技公司高度重視創新療法的研發，到2025年，它們將佔據 56.7%的市場佔有率。

區域展望

北美地區憑藉強勁的研發投入和完善的合約研究組織/合約研發產量組織（CRO/CDMO）生態系統，引領市場，2025年市場規模達到24.8億美元，2026年將達到27.2億美元。

歐洲地區2025年市場規模達到12.3億美元，年複合成長率（CAGR）為9.82%。

亞太地區預計2026年市場規模將達8.4億美元，其中中國和印度分別達到1.5億至1.6億美元。

拉丁美洲地區2025年市場規模達到4.19億美元，中東和非洲（GCC）地區達到6,000萬美元。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 生物偶聯技術進展
  • 主要國家的監管狀況
  • 主要產業趨勢：併購、業務合作等
  • 主要公司新產品發布
  • 概述：拓展生物偶聯的應用

第5章 全球生物偶聯市場分析：洞察與預測（2021-2034）

  • 依產品類型劃分的市場分析、洞察與預測
    • 產品
      • 設備
      • 耗材
    • 服務
      • 客製化合成與偶聯服務
      • 分析與表徵服務
      • 放大生產服務
      • 其他
  • 依技術劃分的市場分析、洞察與預測
    • 化學偶聯
    • 酶促偶聯
    • 點擊化學
    • 光反應交聯
    • 其他
  • 依偶聯物類型劃分的市場分析、洞察與預測
    • 抗體藥物偶聯物偶聯物（ADC）
    • 蛋白質-藥物偶聯物
    • 胜肽-藥物偶聯物
    • 其他
  • 市場分析、洞察與預測：依應用領域劃分
    • 治療藥物
    • 診斷
    • 研發（R&D）
  • 市場分析、洞察與預測：依最終用戶劃分
    • 製藥和生技公司
    • 合約研究組織（CRO）與合約研發生產力組織（CDMO）
    • 學術和研究機構
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美生物偶聯市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲生物偶聯市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第8章 亞太生物偶聯市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 亞太其他地區

第9章 拉丁美洲生物偶聯市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章 中東與非洲生物偶聯市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • GCC成員國
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • Bio Rad Laboratories Inc.
  • Merck KGaA
  • Lonza
  • Catalent, Inc.
  • BD
  • Sartorius AG
  • Danaher
  • Vector Laboratories, Inc.
Product Code: FBI114238

Growth Factors of bioconjugation Market

The global bioconjugation market size was valued at USD 4.78 billion in 2025 and is projected to grow from USD 5.24 billion in 2026 to USD 11.39 billion by 2034, registering a CAGR of 10.20% during the forecast period. North America dominated the bioconjugation market with a market share of 51.82% in 2025, supported by strong biopharmaceutical R&D activities and advanced manufacturing capabilities.

Bioconjugation refers to the chemical linking of two distinct molecules, typically through covalent bonding, to create a functional complex. This technology is widely used in the development of antibody-drug conjugates (ADCs), diagnostics, molecular imaging agents, and targeted therapeutics. Rising demand for targeted therapies, increasing R&D investments, and continuous technological advancements are accelerating the adoption of bioconjugation across therapeutic and diagnostic applications. Additionally, increasing collaborations between biopharmaceutical companies and contract research and manufacturing organizations (CROs/CDMOs) are further supporting market growth.

Major players such as Thermo Fisher Scientific Inc., Agilent Technologies Inc., and Lonza dominate the market owing to their broad service offerings, global presence, and strong technological capabilities.

MARKET DYNAMICS

MARKET DRIVERS

Increasing Focus on Antibody-Drug Conjugates (ADCs)

The growing emphasis on the development of antibody-drug conjugates is a key driver of the bioconjugation market. ADCs combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs, enabling targeted cancer treatment with reduced systemic toxicity. Advancements in site-specific conjugation technologies have improved drug stability, efficacy, and safety profiles, leading to an expanding pipeline of ADCs.

According to data published by Hunan Huateng Pharmaceutical Co., Ltd. in April 2025, a total of 19 ADC drugs have been approved globally to date.

MARKET RESTRAINTS

Regulatory and Safety Challenges

Stringent regulatory requirements and safety concerns pose significant restraints on market growth. Novel bioconjugates face complex regulatory pathways due to risks such as off-target toxicity and premature drug release. These factors result in longer approval timelines and increased development costs, potentially delaying commercialization.

For instance, in July 2023, ADC Therapeutics SA discontinued the Phase II LOTIS-9 trial due to safety and efficacy concerns.

MARKET OPPORTUNITIES

Growing Demand for Companion Diagnostics and Imaging Agents

Bioconjugation plays a crucial role in precision diagnostics and molecular imaging by enabling the attachment of imaging probes, radioactive isotopes, and fluorescent dyes to antibodies or peptides. The increasing adoption of companion diagnostics and imaging agents, particularly in oncology, presents significant growth opportunities for the market.

MARKET CHALLENGES

High Cost and Technical Complexity

The development of bioconjugated therapeutics, especially ADCs, involves complex manufacturing processes, sophisticated equipment, and extensive clinical trials. According to a June 2023 NCBI study, the annual cost of ADC therapy ranges between USD 100,000 and USD 500,000, which limits accessibility and adoption.

BIOCONJUGATION MARKET TRENDS

Rising Outsourcing to CROs and CDMOs

Pharmaceutical and biotechnology companies are increasingly outsourcing conjugation and characterization activities to specialized CROs and CDMOs. This trend allows companies to reduce capital expenditure, access advanced technologies, and accelerate development timelines. In October 2024, Lonza expanded its collaboration with a major biopharmaceutical company for commercial-scale ADC manufacturing.

SEGMENTATION ANALYSIS

By Offering:

The products segment dominated the market with a 75.83% share in 2026, driven by high demand for consumables used in drug development, diagnostics, and research.

By Technique:

The chemical conjugation segment held the largest share at 47.68% in 2026, owing to its cost-effectiveness and wide applicability.

By Conjugate Type:

Antibody-drug conjugates (ADCs) accounted for 56.91% of the market in 2026, supported by strong oncology pipelines.

By Application:

The therapeutics segment dominated with 66.0% share in 2025 and 66.74% in 2026, driven by increasing approvals of targeted therapies.

By End User:

Pharmaceutical & biotechnology companies held 56.7% share in 2025, supported by strong focus on innovative therapeutic development.

REGIONAL OUTLOOK

North America led the market with USD 2.48 billion in 2025 and USD 2.72 billion in 2026, driven by strong R&D investments and a robust CRO/CDMO ecosystem.

Europe reached USD 1.23 billion in 2025, growing at a CAGR of 9.82%.

Asia Pacific attained USD 0.84 billion in 2026, with China and India each reaching USD 0.15-0.16 billion.

Latin America recorded USD 0.419 billion in 2025, while Middle East & Africa (GCC) reached USD 0.06 billion.

COMPETITIVE LANDSCAPE

The bioconjugation market is semi-consolidated, with leading players such as Thermo Fisher Scientific Inc., Merck KGaA, Lonza, Danaher, and Catalent, Inc. focusing on expanding conjugation capabilities, ADC pipelines, and service offerings. Strategic investments and collaborations continue to strengthen competitive positioning.

Conclusion

The global bioconjugation market is positioned for strong growth, driven by rising demand for targeted therapeutics, expanding ADC pipelines, and increasing outsourcing to specialized CROs and CDMOs. With the market valued at USD 4.78 billion in 2025, expected to reach USD 5.24 billion in 2026 and USD 11.39 billion by 2034, sustained innovation and strategic collaborations will remain key growth enablers. Despite regulatory and cost-related challenges, advancements in conjugation technologies and growing applications in diagnostics and therapeutics are expected to support consistent market expansion over the forecast period.

Segmentation By Offering, Technique, Conjugate Type, Application, End User, and Region

By Offering * Products

    • Instruments
      • Chromatography Systems
      • Spectroscopy Instruments
      • Mass Spectrometers
      • Flow Cytometers
      • Others
    • Consumables
      • Reagents & Kits
      • Labels
      • Others
  • Services
    • Custom Synthesis & Conjugation Services
    • Analytical & Characterization Services
    • Scale-up & Manufacturing Services
    • Others

By Technique * Chemical Conjugation

  • Enzyme-Mediated Conjugation
  • Click Chemistry
  • Photoreactive Crosslinking
  • Others

By Conjugate Type * Antibody-Drug Conjugates (ADCs)

  • Protein-Drug Conjugates
  • Peptide-Drug Conjugates
  • Others

By Application * Therapeutics

  • Diagnostics
  • Research & Development

By End User * Pharmaceutical & Biotechnology Companies

  • CROs & CDMOs
  • Academic & Research Institutes
  • Others

By Region * North America (By Offering, Technique, Conjugate Type, Application, End User, and Country)

    • U.S.
    • Canada
  • Europe (By Offering, Technique, Conjugate Type, Application, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Offering, Technique, Conjugate Type, Application, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Offering, Technique, Conjugate Type, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Technique, Conjugate Type, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Bioconjugation
  • 4.2. Regulatory Scenario, By Key Countries/Regions
  • 4.3. Key Industry Developments (Mergers, Acquisitions, and Collaborations etc.)
  • 4.4. New Product Launches, By Key Players
  • 4.5. Overview: Expanding Applications of Bioconjugation

5. Global Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offering
    • 5.1.1. Products
      • 5.1.1.1. Instruments
        • 5.1.1.1.1. Chromatography Systems
        • 5.1.1.1.2. Spectroscopy Instruments
        • 5.1.1.1.3. Mass Spectrometers
        • 5.1.1.1.4. Flow Cytometers
        • 5.1.1.1.5. Others
      • 5.1.1.2. Consumables
        • 5.1.1.2.1. Reagents & Kits
        • 5.1.1.2.2. Labels
        • 5.1.1.2.3. Others
    • 5.1.2. Services
      • 5.1.2.1. Custom Synthesis & Conjugation Services
      • 5.1.2.2. Analytical & Characterization Services
      • 5.1.2.3. Scale-up & Manufacturing Services
      • 5.1.2.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Technique
    • 5.2.1. Chemical Conjugation
    • 5.2.2. Enzyme-Mediated Conjugation
    • 5.2.3. Click Chemistry
    • 5.2.4. Photoreactive Crosslinking
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 5.3.1. Antibody-Drug Conjugates (ADCs)
    • 5.3.2. Protein-Drug Conjugates
    • 5.3.3. Peptide-Drug Conjugates
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Therapeutics
    • 5.4.2. Diagnostics
    • 5.4.3. Research & Development
  • 5.5. Market Analysis, Insights and Forecast - By End User
    • 5.5.1. Pharmaceutical & Biotechnology Companies
    • 5.5.2. CROs & CDMOs
    • 5.5.3. Academic & Research Institutes
    • 5.5.4. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offering
    • 6.1.1. Products
      • 6.1.1.1. Instruments
        • 6.1.1.1.1. Chromatography Systems
        • 6.1.1.1.2. Spectroscopy Instruments
        • 6.1.1.1.3. Mass Spectrometers
        • 6.1.1.1.4. Flow Cytometers
        • 6.1.1.1.5. Others
      • 6.1.1.2. Consumables
        • 6.1.1.2.1. Reagents & Kits
        • 6.1.1.2.2. Labels
        • 6.1.1.2.3. Others
    • 6.1.2. Services
      • 6.1.2.1. Custom Synthesis & Conjugation Services
      • 6.1.2.2. Analytical & Characterization Services
      • 6.1.2.3. Scale-up & Manufacturing Services
      • 6.1.2.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Technique
    • 6.2.1. Chemical Conjugation
    • 6.2.2. Enzyme-Mediated Conjugation
    • 6.2.3. Click Chemistry
    • 6.2.4. Photoreactive Crosslinking
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 6.3.1. Antibody-Drug Conjugates (ADCs)
    • 6.3.2. Protein-Drug Conjugates
    • 6.3.3. Peptide-Drug Conjugates
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Therapeutics
    • 6.4.2. Diagnostics
    • 6.4.3. Research & Development
  • 6.5. Market Analysis, Insights and Forecast - By End User
    • 6.5.1. Pharmaceutical & Biotechnology Companies
    • 6.5.2. CROs & CDMOs
    • 6.5.3. Academic & Research Institutes
    • 6.5.4. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offering
    • 7.1.1. Products
      • 7.1.1.1. Instruments
        • 7.1.1.1.1. Chromatography Systems
        • 7.1.1.1.2. Spectroscopy Instruments
        • 7.1.1.1.3. Mass Spectrometers
        • 7.1.1.1.4. Flow Cytometers
        • 7.1.1.1.5. Others
      • 7.1.1.2. Consumables
        • 7.1.1.2.1. Reagents & Kits
        • 7.1.1.2.2. Labels
        • 7.1.1.2.3. Others
    • 7.1.2. Services
      • 7.1.2.1. Custom Synthesis & Conjugation Services
      • 7.1.2.2. Analytical & Characterization Services
      • 7.1.2.3. Scale-up & Manufacturing Services
      • 7.1.2.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Technique
    • 7.2.1. Chemical Conjugation
    • 7.2.2. Enzyme-Mediated Conjugation
    • 7.2.3. Click Chemistry
    • 7.2.4. Photoreactive Crosslinking
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 7.3.1. Antibody-Drug Conjugates (ADCs)
    • 7.3.2. Protein-Drug Conjugates
    • 7.3.3. Peptide-Drug Conjugates
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Therapeutics
    • 7.4.2. Diagnostics
    • 7.4.3. Research & Development
  • 7.5. Market Analysis, Insights and Forecast - By End User
    • 7.5.1. Pharmaceutical & Biotechnology Companies
    • 7.5.2. CROs & CDMOs
    • 7.5.3. Academic & Research Institutes
    • 7.5.4. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Spain
    • 7.6.5. Italy
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offering
    • 8.1.1. Products
      • 8.1.1.1. Instruments
        • 8.1.1.1.1. Chromatography Systems
        • 8.1.1.1.2. Spectroscopy Instruments
        • 8.1.1.1.3. Mass Spectrometers
        • 8.1.1.1.4. Flow Cytometers
        • 8.1.1.1.5. Others
      • 8.1.1.2. Consumables
        • 8.1.1.2.1. Reagents & Kits
        • 8.1.1.2.2. Labels
        • 8.1.1.2.3. Others
    • 8.1.2. Services
      • 8.1.2.1. Custom Synthesis & Conjugation Services
      • 8.1.2.2. Analytical & Characterization Services
      • 8.1.2.3. Scale-up & Manufacturing Services
      • 8.1.2.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Technique
    • 8.2.1. Chemical Conjugation
    • 8.2.2. Enzyme-Mediated Conjugation
    • 8.2.3. Click Chemistry
    • 8.2.4. Photoreactive Crosslinking
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 8.3.1. Antibody-Drug Conjugates (ADCs)
    • 8.3.2. Protein-Drug Conjugates
    • 8.3.3. Peptide-Drug Conjugates
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Therapeutics
    • 8.4.2. Diagnostics
    • 8.4.3. Research & Development
  • 8.5. Market Analysis, Insights and Forecast - By End User
    • 8.5.1. Pharmaceutical & Biotechnology Companies
    • 8.5.2. CROs & CDMOs
    • 8.5.3. Academic & Research Institutes
    • 8.5.4. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offering
    • 9.1.1. Products
      • 9.1.1.1. Instruments
        • 9.1.1.1.1. Chromatography Systems
        • 9.1.1.1.2. Spectroscopy Instruments
        • 9.1.1.1.3. Mass Spectrometers
        • 9.1.1.1.4. Flow Cytometers
        • 9.1.1.1.5. Others
      • 9.1.1.2. Consumables
        • 9.1.1.2.1. Reagents & Kits
        • 9.1.1.2.2. Labels
        • 9.1.1.2.3. Others
    • 9.1.2. Services
      • 9.1.2.1. Custom Synthesis & Conjugation Services
      • 9.1.2.2. Analytical & Characterization Services
      • 9.1.2.3. Scale-up & Manufacturing Services
      • 9.1.2.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Technique
    • 9.2.1. Chemical Conjugation
    • 9.2.2. Enzyme-Mediated Conjugation
    • 9.2.3. Click Chemistry
    • 9.2.4. Photoreactive Crosslinking
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 9.3.1. Antibody-Drug Conjugates (ADCs)
    • 9.3.2. Protein-Drug Conjugates
    • 9.3.3. Peptide-Drug Conjugates
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Therapeutics
    • 9.4.2. Diagnostics
    • 9.4.3. Research & Development
  • 9.5. Market Analysis, Insights and Forecast - By End User
    • 9.5.1. Pharmaceutical & Biotechnology Companies
    • 9.5.2. CROs & CDMOs
    • 9.5.3. Academic & Research Institutes
    • 9.5.4. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offering
    • 10.1.1. Products
      • 10.1.1.1. Instruments
        • 10.1.1.1.1. Chromatography Systems
        • 10.1.1.1.2. Spectroscopy Instruments
        • 10.1.1.1.3. Mass Spectrometers
        • 10.1.1.1.4. Flow Cytometers
        • 10.1.1.1.5. Others
      • 10.1.1.2. Consumables
        • 10.1.1.2.1. Reagents & Kits
        • 10.1.1.2.2. Labels
        • 10.1.1.2.3. Others
    • 10.1.2. Services
      • 10.1.2.1. Custom Synthesis & Conjugation Services
      • 10.1.2.2. Analytical & Characterization Services
      • 10.1.2.3. Scale-up & Manufacturing Services
      • 10.1.2.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Technique
    • 10.2.1. Chemical Conjugation
    • 10.2.2. Enzyme-Mediated Conjugation
    • 10.2.3. Click Chemistry
    • 10.2.4. Photoreactive Crosslinking
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 10.3.1. Antibody-Drug Conjugates (ADCs)
    • 10.3.2. Protein-Drug Conjugates
    • 10.3.3. Peptide-Drug Conjugates
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Therapeutics
    • 10.4.2. Diagnostics
    • 10.4.3. Research & Development
  • 10.5. Market Analysis, Insights and Forecast - By End User
    • 10.5.1. Pharmaceutical & Biotechnology Companies
    • 10.5.2. CROs & CDMOs
    • 10.5.3. Academic & Research Institutes
    • 10.5.4. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Agilent Technologies Inc.
    • 11.2.2. Thermo Fisher Scientific Inc.
    • 11.2.3. Bio Rad Laboratories Inc.
    • 11.2.4. Merck KGaA
    • 11.2.5. Lonza
    • 11.2.6. Catalent, Inc.
    • 11.2.7. BD
    • 11.2.8. Sartorius AG
    • 11.2.9. Danaher
    • 11.2.10. Vector Laboratories, Inc.

List of Tables

  • Table 1: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 2: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 3: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 4: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 5: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 6: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 7: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 8: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 9: Global Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 10: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Region, 2021-2034
  • Table 11: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 12: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 13: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 14: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 15: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 16: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 17: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 18: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 19: North America Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 20: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 21: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 22: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 23: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 24: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 25: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 26: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 27: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 28: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 29: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 30: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Country/Sub-Region, 2021-2034
  • Table 31: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 32: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 33: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 34: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 35: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 36: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 37: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 38: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 39: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 40: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Country/Sub-Region, 2021-2034
  • Table 41: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 42: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 43: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 44: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 45: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 46: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 47: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 48: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 49: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 50: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Country/Sub-Region, 2021-2034
  • Table 51: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 52: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 53: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 54: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 55: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 56: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 57: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 58: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 59: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 60: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Country/Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Bioconjugation Market Revenue Breakdown (USD Billion, %) By Region, 2025 & 2034
  • Figure 2: Global Bioconjugation Market Value Share (%), By Offering, 2025 & 2034
  • Figure 3: Global Bioconjugation Market Value Share (%), By Technique, 2025 & 2034
  • Figure 4: Global Bioconjugation Market Value Share (%), By Conjugate Type, 2025 & 2034
  • Figure 5: Global Bioconjugation Market Value Share (%), By Application, 2025 & 2034
  • Figure 6: Global Bioconjugation Market Value Share (%), By End User, 2025 & 2034
  • Figure 7: Global Bioconjugation Market Value (USD Billion), By Region, 2025 & 2034
  • Figure 8: North America Bioconjugation Market Value (USD Billion), By Offering, 2025 & 2034
  • Figure 9: North America Bioconjugation Market Value Share (%), By Offering, 2025
  • Figure 10: North America Bioconjugation Market Value (USD Billion), By Technique, 2025 & 2034
  • Figure 12: North America Bioconjugation Market Value Share (%), By Technique, 2025
  • Figure 12: North America Bioconjugation Market Value (USD Billion), By Conjugate Type, 2025 & 2034
  • Figure 13: North America Bioconjugation Market Value Share (%), By Conjugate Type, 2025
  • Figure 14: North America Bioconjugation Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 15: North America Bioconjugation Market Value Share (%), By Application, 2025
  • Figure 16: North America Bioconjugation Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 17: North America Bioconjugation Market Value Share (%), By End User, 2025
  • Figure 18: North America Bioconjugation Market Value (USD Billion), By Country, 2025 & 2034
  • Figure 19: North America Bioconjugation Market Value Share (%), By Country, 2025
  • Figure 20: Europe Bioconjugation Market Value (USD Billion), By Offering, 2025 & 2034
  • Figure 21: Europe Bioconjugation Market Value Share (%), By Offering, 2025
  • Figure 22: Europe Bioconjugation Market Value (USD Billion), By Technique, 2025 & 2034
  • Figure 23: Europe Bioconjugation Market Value Share (%), By Technique, 2025
  • Figure 24: Europe Bioconjugation Market Value (USD Billion), By Conjugate Type, 2025 & 2034
  • Figure 25: Europe Bioconjugation Market Value Share (%), By Conjugate Type, 2025
  • Figure 26: Europe Bioconjugation Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 27: Europe Bioconjugation Market Value Share (%), By Application, 2025
  • Figure 28: Europe Bioconjugation Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 29: Europe Bioconjugation Market Value Share (%), By End User, 2025
  • Figure 30: Europe Bioconjugation Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe Bioconjugation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific Bioconjugation Market Value (USD Billion), By Offering, 2025 & 2034
  • Figure 33: Asia Pacific Bioconjugation Market Value Share (%), By Offering, 2025
  • Figure 34: Asia Pacific Bioconjugation Market Value (USD Billion), By Technique, 2025 & 2034
  • Figure 35: Asia Pacific Bioconjugation Market Value Share (%), By Technique, 2025
  • Figure 36: Asia Pacific Bioconjugation Market Value (USD Billion), By Conjugate Type, 2025 & 2034
  • Figure 37: Asia Pacific Bioconjugation Market Value Share (%), By Conjugate Type, 2025
  • Figure 38: Asia Pacific Bioconjugation Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 39: Asia Pacific Bioconjugation Market Value Share (%), By Application, 2025
  • Figure 40: Asia Pacific Bioconjugation Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 41: Asia Pacific Bioconjugation Market Value Share (%), By End User, 2025
  • Figure 42: Asia Pacific Bioconjugation Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Bioconjugation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America Bioconjugation Market Value (USD Billion), By Offering, 2025 & 2034
  • Figure 45: Latin America Bioconjugation Market Value Share (%), By Offering, 2025
  • Figure 46: Latin America Bioconjugation Market Value (USD Billion), By Technique, 2025 & 2034
  • Figure 47: Latin America Bioconjugation Market Value Share (%), By Technique, 2025
  • Figure 48: Latin America Bioconjugation Market Value (USD Billion), By Conjugate Type, 2025 & 2034
  • Figure 49: Latin America Bioconjugation Market Value Share (%), By Conjugate Type, 2025
  • Figure 50: Latin America Bioconjugation Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 51: Latin America Bioconjugation Market Value Share (%), By Application, 2025
  • Figure 52: Latin America Bioconjugation Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 53: Latin America Bioconjugation Market Value Share (%), By End User, 2025
  • Figure 54: Latin America Bioconjugation Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America Bioconjugation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa Bioconjugation Market Value (USD Billion), By Offering, 2025 & 2034
  • Figure 57: Middle East & Africa Bioconjugation Market Value Share (%), By Offering, 2025
  • Figure 58: Middle East & Africa Bioconjugation Market Value (USD Billion), By Technique, 2025 & 2034
  • Figure 59: Middle East & Africa Bioconjugation Market Value Share (%), By Technique, 2025
  • Figure 60: Middle East & Africa Bioconjugation Market Value (USD Billion), By Conjugate Type, 2025 & 2034
  • Figure 61: Middle East & Africa Bioconjugation Market Value Share (%), By Conjugate Type, 2025
  • Figure 62: Middle East & Africa Bioconjugation Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 63: Middle East & Africa Bioconjugation Market Value Share (%), By Application, 2025
  • Figure 64: Middle East & Africa Bioconjugation Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 65: Middle East & Africa Bioconjugation Market Value Share (%), By End User, 2025
  • Figure 66: Middle East & Africa Bioconjugation Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Bioconjugation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global Bioconjugation Market Share (%), By Company, 2025